Boji Pharmaceutical Group
Boji Pharmaceutical Group, a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative healthcare solutions, focusing on both prescription and over-the-counter medications. With a diverse portfolio that includes unique formulations and advanced drug delivery systems, Boji Pharmaceutical Group is committed to enhancing patient outcomes. The company has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. Renowned for its dedication to quality and research, Boji continues to make strides in the pharmaceutical landscape, contributing to global health advancements.
DitchCarbon Score
How does Boji Pharmaceutical Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boji Pharmaceutical Group's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Boji Pharmaceutical Group's reported carbon emissions
Boji Pharmaceutical Group, headquartered in China, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Boji Pharmaceutical Group to establish clear climate strategies and targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boji Pharmaceutical Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
